Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.49 USD 0.08% Market Closed
Market Cap: 801.1m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

CDMO Price Targets Summary
Avid Bioservices Inc

Wall Street analysts forecast CDMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDMO is 12.75 USD with a low forecast of 12.63 USD and a high forecast of 13.13 USD.

CDMO Lowest Forecast
Wall Street Target
12.63 USD
1% Upside
CDMO Average Forecast
Wall Street Target
12.75 USD
2% Upside
CDMO Highest Forecast
Wall Street Target
13.13 USD
5% Upside
Lowest
Price Target
12.63 USD
1% Upside
Average
Price Target
12.75 USD
2% Upside
Highest
Price Target
13.13 USD
5% Upside
Avid Bioservices Inc Competitors:
Price Targets
VERV
Verve Therapeutics Inc
339% Upside
STOK
Stoke Therapeutics Inc
227% Upside
688520
Sinocelltech Group Ltd
66% Upside
C
COYA
Coya Therapeutics Inc
138% Upside
VERV
Verve Therapeutics Inc
339% Upside
STOK
Stoke Therapeutics Inc
227% Upside
688520
Sinocelltech Group Ltd
66% Upside
C
COYA
Coya Therapeutics Inc
138% Upside
300896
Imeik Technology Development Co Ltd
36% Upside
T
4891
TMS Co Ltd
373% Upside
BIOPOR
Bioporto A/S
120% Upside
ASND
Ascendis Pharma A/S
34% Upside

Revenue
Forecast

Revenue Estimate
Avid Bioservices Inc

For the last 8 years the compound annual growth rate for Avid Bioservices Inc's revenue is 15%. The projected CAGR for the next 3 years is 19%.

15%
Past Growth
19%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Avid Bioservices Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Avid Bioservices Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

See Also

Summary
CDMO intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDMO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDMO stock valuation using valuation multiples.
Wall Street Estimates
CDMO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDMO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CDMO's stock price target?
Price Target
12.75 USD

According to Wall Street analysts, the average 1-year price target for CDMO is 12.75 USD with a low forecast of 12.63 USD and a high forecast of 13.13 USD.

What is Avid Bioservices Inc's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Avid Bioservices Inc's revenue is 15%. The projected CAGR for the next 3 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.